The stock market has dropped lately, with the S&P 500 index down 3.3% over the last month through March 25. Growth stocks, as ...

But recent short-term worries about the economy as well as specific worries raised about the development timeline for AI, and ...

Neuronetics' strategic acquisitions, including Greenbrook, and FDA approvals are expected to drive revenue growth. See why ...

Eli Lilly and Novo Nordisk occupy leading positions in the obesity and diabetes markets. Find out which is the better bargain ...

We recently published a list of 12 High Growth Non-Tech Stocks That Are Profitable in 2025. In this article, we are going to ...